These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 497523)

  • 21. A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists.
    Moloney GP; Robertson AD; Martin GR; MacLennan S; Mathews N; Dodsworth S; Sang PY; Knight C; Glen R
    J Med Chem; 1997 Jul; 40(15):2347-62. PubMed ID: 9240350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
    Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW; Thompson JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
    Cohen ML; Colbert WE
    J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
    Frenken M; Kaumann AJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):707-13. PubMed ID: 2760851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of MCI-9042, a novel 5-HT2 receptor blocker on blood vessels of the rat.
    Pawlak D; Małyszko J; Myśliwiec M; Takada A; Buczko W
    Acta Physiol Hung; 1996; 84(3):323-4. PubMed ID: 9219624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors.
    Brazenor RM; Angus JA
    J Pharmacol Exp Ther; 1981 Aug; 218(2):530-6. PubMed ID: 6114172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schistosoma mansoni: effects of serotonin and serotonin receptor antagonists on motility and length of primary sporocysts in vitro.
    Boyle JP; Zaide JV; Yoshino TP
    Exp Parasitol; 2000 Apr; 94(4):217-26. PubMed ID: 10831389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Hydroxytryptamine-induced hypothermia in rats as an in vivo model for the quantitative study of 5-hydroxytryptamine receptors.
    Cox B; Lee TF
    J Pharmacol Methods; 1981 Jan; 5(1):43-51. PubMed ID: 6115102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism by some ergot derivatives of 5-HT-induced vasoconstriction.
    Conolan S; Taylor DA
    Eur J Pharmacol; 1986 Apr; 123(2):299-302. PubMed ID: 3709667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.
    Boullin DJ; Glenton PA
    Br J Pharmacol; 1978 Apr; 62(4):537-42. PubMed ID: 26445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The action of 5-hydroxytryptamine and some of its antagonists on the umbilical vessels of the human placenta.
    ASTROM A; SAMELIUS U
    Br J Pharmacol Chemother; 1957 Dec; 12(4):410-4. PubMed ID: 13489166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of spasmogens from rat isolated lungs by tryptamines.
    Bakhle YS; Smith TW
    Eur J Pharmacol; 1977 Nov; 46(1):31-9. PubMed ID: 21802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactam and oxazolidinone derived potent 5-hydroxytryptamine 6 receptor antagonists.
    Hostetler G; Dunn D; McKenna BA; Kopec K; Chatterjee S
    Bioorg Med Chem Lett; 2014 May; 24(9):2094-7. PubMed ID: 24704027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Comparison of the blocking effects of antagonists of adrenaline and 5-hydroxytryptamine on their mutual receptors.
    Görlitz BD; Frey HH
    J Pharm Pharmacol; 1973 Aug; 25(8):651-3. PubMed ID: 4148436
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular effects of neurotoxic indolethylamines.
    Göthert M; Klupp N
    Ann N Y Acad Sci; 1978 Jun; 305():457-77. PubMed ID: 280256
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation of inhibitory activity of tryptamine derivatives on serotonin uptake in thrombocyte with van der Waals volume.
    Gupta SP; Singh P; Bindal MC
    Arzneimittelforschung; 1981; 31(12):2053-5. PubMed ID: 7199296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of chlorpromazine on two vasoconstrictor tones in the rat.
    Iriuchijima J
    Tohoku J Exp Med; 2001 Sep; 195(1):55-60. PubMed ID: 11780724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism between chlorpromazine and noradrenaline in blood vessels of the hands.
    DUFF RS; GINSBURG J
    Br J Pharmacol Chemother; 1956 Sep; 11(3):318-22. PubMed ID: 13364208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.